Company news

Scienture Holdings, Inc. news in 2024

Scienture Holdings, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025

December 16, 2024

Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041

December 9, 2024

Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement

November 25, 2024

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”

September 23, 2024

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.

September 19, 2024

TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team

August 4, 2024

TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million

July 25, 2024

TRxADE Health, Inc. Announces Special Cash Dividend

July 8, 2024

TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale

June 26, 2024

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

May 28, 2024

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

April 22, 2024

Trxade health, Inc files its 3Q 10Q

January 16, 2024

Decks in 2024